20-45950314-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_022095.4(ZNF335):​c.3392G>A​(p.Arg1131Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00024 in 1,568,028 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1131T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )

Consequence

ZNF335
NM_022095.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 3.22

Publications

1 publications found
Variant links:
Genes affected
ZNF335 (HGNC:15807): (zinc finger protein 335) The protein encoded by this gene enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. The encoded protein may function by altering local chromatin structure. [provided by RefSeq, Jul 2008]
ZNF335 Gene-Disease associations (from GenCC):
  • microcephalic primordial dwarfism due to ZNF335 deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00505051).
BP6
Variant 20-45950314-C-T is Benign according to our data. Variant chr20-45950314-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 130804.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00119 (181/152216) while in subpopulation AFR AF = 0.00407 (169/41554). AF 95% confidence interval is 0.00357. There are 1 homozygotes in GnomAd4. There are 79 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF335NM_022095.4 linkc.3392G>A p.Arg1131Lys missense_variant Exon 22 of 28 ENST00000322927.3 NP_071378.1 Q9H4Z2-1Q8IW09
ZNF335XM_047440363.1 linkc.3392G>A p.Arg1131Lys missense_variant Exon 21 of 27 XP_047296319.1
ZNF335XM_005260504.5 linkc.3389G>A p.Arg1130Lys missense_variant Exon 21 of 27 XP_005260561.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF335ENST00000322927.3 linkc.3392G>A p.Arg1131Lys missense_variant Exon 22 of 28 1 NM_022095.4 ENSP00000325326.2 Q9H4Z2-1

Frequencies

GnomAD3 genomes
AF:
0.00119
AC:
181
AN:
152098
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00408
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000374
AC:
81
AN:
216820
AF XY:
0.000252
show subpopulations
Gnomad AFR exome
AF:
0.00352
Gnomad AMR exome
AF:
0.000809
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000138
AC:
195
AN:
1415812
Hom.:
1
Cov.:
34
AF XY:
0.000109
AC XY:
76
AN XY:
698654
show subpopulations
African (AFR)
AF:
0.00415
AC:
134
AN:
32308
American (AMR)
AF:
0.000862
AC:
35
AN:
40586
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22778
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39282
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78502
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51546
Middle Eastern (MID)
AF:
0.000181
AC:
1
AN:
5522
European-Non Finnish (NFE)
AF:
0.00000368
AC:
4
AN:
1086916
Other (OTH)
AF:
0.000360
AC:
21
AN:
58372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00119
AC:
181
AN:
152216
Hom.:
1
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00407
AC:
169
AN:
41554
American (AMR)
AF:
0.000459
AC:
7
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68010
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000571
Hom.:
0
Bravo
AF:
0.00144
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000338
AC:
41

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Mar 25, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 10, 2014
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ZNF335-related disorder Benign:1
Feb 09, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.045
T
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.50
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.60
T
M_CAP
Benign
0.0089
T
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.5
N
PhyloP100
3.2
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
0.18
N
REVEL
Benign
0.055
Sift
Benign
0.32
T
Sift4G
Benign
0.99
T
Polyphen
0.060
B
Vest4
0.14
MVP
0.29
MPC
0.15
ClinPred
0.024
T
GERP RS
2.9
Varity_R
0.067
gMVP
0.22
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114864530; hg19: chr20-44578953; COSMIC: COSV59815985; COSMIC: COSV59815985; API